Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auxora in acute kidney injury with acute hypoxemic respiratory failure
NCT06374797Phase 2Terminated
- Sponsor
- CalciMedica
- Start
- Jul 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Auxora in acute kidney injury (AKI), acute hypoxemic respiratory failure (AHRF), sponsored by CalciMedica. Started Jul 2024; status: terminated.
02
Drugs
Auxora
03
Conditions
acute kidney injury (AKI)acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT06374797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06374797.